Home
>
National Drug Code (NDC)
>
PATANASE
PATANASE - 0065-0332-30 - (olopatadine hydrochloride)
Drug Information of PATANASE
| Product NDC: | 0065-0332 |
| Proprietary Name: | PATANASE |
| Non Proprietary Name: | olopatadine hydrochloride |
| Active Ingredient(s): | 665 ug/1 & nbsp; olopatadine hydrochloride |
| Administration Route(s): | NASAL |
| Dosage Form(s): | SPRAY, METERED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PATANASE
| Product NDC: | 0065-0332 |
| Labeler Name: | ALCON LABORATORIES, INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021861 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080428 |
Package Information of PATANASE
| Package NDC: | 0065-0332-30 |
| Package Description: | 240 SPRAY, METERED in 1 BOTTLE (0065-0332-30) |
NDC Information of PATANASE
| NDC Code | 0065-0332-30 |
| Proprietary Name | PATANASE |
| Package Description | 240 SPRAY, METERED in 1 BOTTLE (0065-0332-30) |
| Product NDC | 0065-0332 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | olopatadine hydrochloride |
| Dosage Form Name | SPRAY, METERED |
| Route Name | NASAL |
| Start Marketing Date | 20080428 |
| Marketing Category Name | NDA |
| Labeler Name | ALCON LABORATORIES, INC. |
| Substance Name | OLOPATADINE HYDROCHLORIDE |
| Strength Number | 665 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |
